In Vitro Fertilization IVF

Neurocrine Looks Well Positioned

29 Jul 2010

We regard the collaboration deal with Abbott Labs as a homerun.

Safeguard Scientifics Announces Second Quarter 2010 Financial Results

29 Jul 2010

WAYNE, Pa.----Safeguard Scientifics, Inc. , a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009.

Teva Respiratory reports positive results from BDP HFA Nasal Aerosol Phase III trial in seasonal allergic rhinitis

29 Jul 2010

Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy endpoints, demonstrating a statistically significant benefit as compared to placebo. Furthermore, the safety profile of BDP HFA Nasal ...